Author

Julie Bruneau

CLINICAL PRESENTATION AND PROGNOSIS OF SMALL BOWEL ADENOCARCINOMA IN CELIAC DISEASE PATIENTS
CLINICAL PRESENTATION AND PROGNOSIS OF SMALL BOWEL ADENOCARCINOMA IN CELIAC DISEASE PATIENTS

Julie Bruneau  et al.

LONG-TERM FOLLOW-UP OF PATIENTS WITH TYPE 2 REFRACTORY CELIAC DISEASE TREATED WITH AMG 714, AN ANTI-INTERLEUKIN 15 MONOCLONAL ANTIBODY, AT GEORGES POMPIDOU HOSPITAL
LONG-TERM FOLLOW-UP OF PATIENTS WITH TYPE 2 REFRACTORY CELIAC DISEASE TREATED WITH AMG 714, AN ANTI-INTERLEUKIN 15 MONOCLONAL ANTIBODY, AT GEORGES POMPIDOU HOSPITAL

Julie Bruneau  et al.

NATURAL HISTORY OF CELIAC DISEASE: COMPARISON BETWEEN CHILDHOOD AND ADULT-ONSET DISEASE
NATURAL HISTORY OF CELIAC DISEASE: COMPARISON BETWEEN CHILDHOOD AND ADULT-ONSET DISEASE

Julie Bruneau  et al.

PREDICTIVE FACTORS FOR LONG-TERM COMPLICATIONS IN CELIAC DISEASE: A LARGE RETROSPECTIVE STUDY FROM THE CELAC GROUP
PREDICTIVE FACTORS FOR LONG-TERM COMPLICATIONS IN CELIAC DISEASE: A LARGE RETROSPECTIVE STUDY FROM THE CELAC GROUP

Julie Bruneau  et al.

DIAGNOSTIC YIELD OF CAPSULE ENDOSCOPY AND ENTEROSCOPY IN THE DIAGNOSIS OF INTESTINAL LYMPHOMA IN REFRACTORY CELIAC DISEASE TYPE 2 PATIENTS
DIAGNOSTIC YIELD OF CAPSULE ENDOSCOPY AND ENTEROSCOPY IN THE DIAGNOSIS OF INTESTINAL LYMPHOMA IN REFRACTORY CELIAC DISEASE TYPE 2 PATIENTS

Julie Bruneau  et al.

PREDICTIVE FACTORS FOR ENTEROPATHY ASSOCIATED T-CELL LYMPHOMA DEVELOPMENT IN REFRACTORY CELIAC DISEASE TYPE II PATIENTS
PREDICTIVE FACTORS FOR ENTEROPATHY ASSOCIATED T-CELL LYMPHOMA DEVELOPMENT IN REFRACTORY CELIAC DISEASE TYPE II PATIENTS

Julie Bruneau  et al.

Item 1 - 6 / 6
1